BioCorRx Inc. (23)
Browse by Contract Category
Contracts
-
Form of Indemnification Agreement
(Filed With SEC on January 23, 2023)
-
Form of Murthy Director Agreement
(Filed With SEC on January 23, 2023)
-
Form of Exchange Agreement entered into with Messrs. Galligan and Lucido in Sept 2022
(Filed With SEC on November 14, 2022)
-
BioCorRx Inc. 2022 Omnibus Securities and Incentive Plan
(Filed With SEC on April 28, 2022)
-
Inter-Company License Agreement by and between BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., effective September 22, 2021
(Filed With SEC on March 31, 2022)
-
Second Amendment To Lease, dated July 11, 2019, by and between BioCorRx Inc. and Axis Campus Owner, LLC
(Filed With SEC on November 14, 2019)
-
Form of Subscription Agreement by and between BioCorRx Inc. and the Purchaser initially effective May 6, 2022
(Filed With SEC on May 12, 2022)
-
Form of Warrant
(Filed With SEC on May 12, 2022)
-
Description of securities registered under Section 12 of the Exchange Act of 1934
(Filed With SEC on March 31, 2022)
-
Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective January 12, 2022
(Filed With SEC on January 19, 2022)
-
Description of securities registered under Section 12 of the Exchange Act of 1934
(Filed With SEC on March 31, 2021)
-
Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts entered into on February 23, 2021
(Filed With SEC on February 26, 2021)
-
Form of Galligan Director Agreement
(Filed With SEC on February 22, 2021)
-
Lock-Up Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC
(Filed With SEC on October 4, 2019)
-
Conversion Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC
(Filed With SEC on October 4, 2019)
-
Statement of Work 2 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019
(Filed With SEC on June 14, 2019)
-
Statement of Work 1 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019
(Filed With SEC on June 14, 2019)
-
Master Services Agreement by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 24, 2019
(Filed With SEC on June 14, 2019)
-
Subscription and Royalty Agreement by and between BioCorRx Inc. and J and R Galligan Revocable Trust
(Filed With SEC on April 3, 2019)
-
Subscription and Royalty Agreement by and between BioCorRx Inc. and Louis and Carolyn Lucido CRT LLC
(Filed With SEC on April 3, 2019)
-
Subscription Agreement dated February 22, 2019
(Filed With SEC on March 8, 2019)
-
Form of Director Agreement
(Filed With SEC on March 7, 2019)
-
Form of Director Agreement
(Filed With SEC on February 22, 2019)